Skip to main contentSkip to navigation
Sirius Investors

YIHCF Stock: YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Stock Price, Analysis & Insights

Get live YIHCF stock price $0.55, comprehensive YiChang HEC ChangJiang Pharmaceutical Co., Ltd. stock analysis, charts, news, and expert forecast. Real-time YIHCF stock data and investment insights.

0.55
0.00%Today
YIHCFYiChang HEC ChangJiang Pharmaceutical Co., Ltd. • Other OTC • Healthcare
Market Cap
643.13M
Volume
25.00K
52W High
0.55
52W Low
0.55

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise primarily engaged in the development, manufacturing, and distribution of medicinal products. Operating within the People's Republic of China, its therapeutic exper...

Company Information

CEO
Juncai Jiang
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4618

Contact Information

Address
No. 38, Binjiang Road
Country
CN

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: 0.11) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for YiChang HEC ChangJiang Pharmaceutical Co., Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
  • Investors should consider how YiChang HEC ChangJiang Pharmaceutical Co., Ltd. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

643.13M

P/E Ratio (TTM)

-5.00

Beta

0.11

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.